A comment on “Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was”

Herman, W.H., Kuo, S., Zhang, P., Group, f.t.D.P.P.R. (2024). A comment on “Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was”. https://doi.org/10.1111/dom.16124

Herman, William H., et al.. "A comment on “Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was”". CrossRef, 2024. doi:10.1111/dom.16124.

@article{herman2024, author = {William H. Herman and Shihchen Kuo and Ping Zhang and for the Diabetes Prevention Program Research Group}, title = {A comment on “Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was”}, year = {2024}, journal = {CrossRef}, doi = {10.1111/dom.16124}, url = {https://doi.org/10.1111/dom.16124}, }

A comment on “Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was”

Penulis (4)

Format Sitasi

Akses Cepat